Erick Lucera - EVP, CHIEF FINANCIAL OFFICER at Editas Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Evp, Chief Financial Officer
Stock Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Erick Lucera - trading volume in the past year for Editas Medicine, Inc.

Holdings reported by Erick Lucera for Editas Medicine, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 116,829 $656 K $5.61 May 20, 2024 Direct
Stock Option (right to buy) 106,000 Mar 2, 2024 Direct Common Stock

Transactions reported by Erick Lucera for Editas Medicine, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership